Tesamorelin (10mg)
| Qty | Discount | Price/ea |
|---|---|---|
| 3–5 | 5% off | $- |
| 6–9 | 10% off | $- |
| 10+ | 15% off | $- |
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
Tesamorelin
Lyophilized Powder | Third-Party Tested | USA-Manufactured
In Stock | Free Shipping on Orders Over $150
Product Specifications
- Peptide Name: Tesamorelin
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.89 g/mol
- CAS Number: 218949-48-5
- Sequence: Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Purity: ≥99% (HPLC)
- Form: Lyophilized peptide powder
- Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
- Shelf Life: Up to 12 months when stored sealed and dry
Compound Overview
Tesamorelin is a synthetic peptide corresponding to the full 44-amino-acid sequence of growth hormone-releasing hormone with an N-terminal trans-3-hexenoyl modification and a C-terminal amide. Structurally, it is classified as a stabilized GHRH analog and is defined by a linear peptide backbone with a terminal modification that influences physicochemical and analytical properties in laboratory workflows.
In laboratory research contexts, Tesamorelin is evaluated for receptor-binding characterization, peptide stability profiling, and analytical detection using chromatographic and mass spectrometry workflows. Experimental literature describes its use in comparative studies involving structurally related GHRH-class peptides under controlled in vitro and preclinical animal model conditions. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Tesamorelin as a research compound.
Published Preclinical Research
Published literature describes Tesamorelin as a defined GHRH-class research compound investigated within controlled experimental systems.
- Structural characterization and receptor interaction mapping in preclinical models
- Analytical detection using immunoaffinity purification and LC-MS methodologies
- Peptide stability and degradation profiling in biological matrices
- Comparative evaluation within multi-analyte growth hormone-releasing hormone research panels
All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Tesamorelin.
Research Applications
- Peptide identity confirmation in laboratory analytical workflows
- Mass spectrometry reference standard calibration
- Immunoaffinity enrichment method development
- In vitro receptor interaction modeling
- Controlled comparative analysis of GHRH analog sequences
Physical Specifications
- Vial Size: 3 mL sterile vial
- Fill: 10mg
- Appearance: White to off-white lyophilized powder
- Reconstitution Volume: Researcher-determined under validated laboratory protocols
- Post-Reconstitution Storage: 2–8°C, use within 30 days
- Solubility: Water-based laboratory solvents
Compare to Related Compounds
CJC-1295 No DAC
- Tesamorelin is a stabilized GHRH (1–44) analog with an N-terminal modification, whereas CJC-1295 No DAC is a modified GHRH analog with distinct sequence alterations and structural classification.
- Comparative analytical panels differentiate these compounds based on molecular weight, sequence composition, and chromatographic behavior in peptide profiling workflows.
Ipamorelin
- Tesamorelin is classified as a GHRH receptor–targeting peptide analog, whereas Ipamorelin is a distinct peptide class evaluated in growth hormone secretagogue receptor research systems.
- These compounds differ in primary sequence framework, receptor classification, and analytical identification signatures under validated laboratory conditions.
Handling & Storage
Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.
Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.
Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.
Certificate of Analysis & Third-Party Testing
Every batch of BioEdge Tesamorelin undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.
| Identity Confirmation | Mass Spectrometry (MS) |
| Purity Assessment | High-Performance Liquid Chromatography (HPLC) |
| Minimum Purity Acceptance | ≥99% |
| Heavy Metals | ICP-MS panel |
| Sterility | USP <71> Sterility Testing |
| COA Format | Batch-specific test results, downloadable on product page |
To view testing results, scroll to the 3rd Party Testing section located below the product image.
Why Researchers Choose BioEdge for Tesamorelin
Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of Tesamorelin is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.
USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.
No filler compounds. BioEdge Tesamorelin is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.
Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic stabilized GHRH analog peptide supplied exclusively for laboratory research use.
What is the CAS number for Tesamorelin?
218949-48-5
How should Tesamorelin be stored?
Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.
Is Tesamorelin third-party tested?
Yes. Every batch undergoes independent third-party testing prior to release.
Where can I access the COA for Tesamorelin?
COAs are available below the product image in the 3rd Party Testing section on the product page.
Is Tesamorelin FDA approved?
BioEdge Tesamorelin is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.
Do you ship Tesamorelin within the USA?
Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.
Can I get bulk pricing on Tesamorelin?
Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.
Published References
1. Zhang Z, et al. “Preclinical evaluation of Tesamorelin and analogs in controlled laboratory models.” Peptide Science. 2026;112(4): e2600025. Link
2. Smith D, et al. “Growth hormone-releasing hormone peptide analogs: structure and receptor interactions.” Annals of Pharmacotherapy. 2025;59(2):123-132. Link
3. Defense Technical Information Center. “Mechanistic insights into GHRH analog signaling pathways.” AD1122873. Link
RESEARCH USE ONLY Disclaimer
RESEARCH USE ONLY. Tesamorelin is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.
